Vitamin D therapy to reduce cardiovascular risk in type two diabetes - the next steps

Not Applicable

Completed

• Conditions: Type two diabetes mellitus; Nutritional, Metabolic, Endocrine; Diabetes

• Registration Number: ISRCTN50587697
• Lead Sponsor: niversity of Dundee (UK)

Brief Summary

1. 2010 results in http://www.ncbi.nlm.nih.gov/pubmed/20596692

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2007-09-27
• Study Completion: 2010-01-31
• Last Update Posted: 26 March 2018

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

Diagnosis of type two diabetes mellitus.

Exclusion Criteria

1. Taking vitamin D supplements
2. Serum 25 hydroxy vitamin D level of greater than 100 nmol/L
3. Serum creatinine greater than 200 umol/l
4. Liver function tests greater than three times the upper limit of normal
5. Hyper- or hypo-calcaemia (corrected calcium greater than 2.55 or less than 2.15 mmol/l, respectively)
6. Metastatic malignancy
7. Inability to give informed consent

Study & Design

• Study Type: Interventional
• Study Design: Not specified